Carisoprodol: an unrecognized drug of abuse
- PMID: 11888078
- DOI: 10.1309/4KTM-CY6N-572P-7ERD
Carisoprodol: an unrecognized drug of abuse
Abstract
During a 6-month monitoring period, carisoprodol was detected in the urine specimens of 19 patients for whom drug screening had been ordered for purposes of patient care. The clinical history suggested that in 7 cases the drug was abused or implicated in a suicide attempt or gesture. In another 7 cases, the drug was used primarily for medical purposes, and in 5 cases the reason for use could not be determined. One patient ingested homemade tablets that were found to contain carisoprodol. In an additional case, the drug was detected in breast milk. Physical findings, clinical history, and treatment are described, and the profile of a typical carisoprodol user is discussed. It seems that carisoprodol has become an unrecognized drug of abuse, at least in our community. This drug and its metabolite, meprobamate, should be included in comprehensive drug screening.
Similar articles
-
Role of drug testing as an early warning programme: the experience of the Republic of Korea.Bull Narc. 2005;57(1-2):231-48. Bull Narc. 2005. PMID: 21338024
-
Is the frequency of carisoprodol withdrawal syndrome increasing?Pharmacotherapy. 2007 Oct;27(10):1462-6. doi: 10.1592/phco.27.10.1462. Pharmacotherapy. 2007. PMID: 17896902
-
Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.J Anal Toxicol. 2012 Apr;36(3):177-81. doi: 10.1093/jat/bks011. J Anal Toxicol. 2012. PMID: 22417833
-
Psychoactive drug abuse in older adults.Am J Geriatr Pharmacother. 2006 Dec;4(4):380-94. doi: 10.1016/j.amjopharm.2006.10.002. Am J Geriatr Pharmacother. 2006. PMID: 17296542 Review.
-
Carisoprodol: update on abuse potential and legal status.South Med J. 2012 Nov;105(11):619-23. doi: 10.1097/SMJ.0b013e31826f5310. South Med J. 2012. PMID: 23128807 Review.
Cited by
-
Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.Int J Legal Med. 2007 Sep;121(5):403-9. doi: 10.1007/s00414-006-0139-1. Epub 2006 Nov 18. Int J Legal Med. 2007. PMID: 17115170
-
Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers.J Clin Med. 2022 Feb 21;11(4):1141. doi: 10.3390/jcm11041141. J Clin Med. 2022. PMID: 35207414 Free PMC article.
-
Abuse Potential of Soma: the GABA(A) Receptor as a Target.Mol Cell Pharmacol. 2009 Jan 1;1(4):180-186. Mol Cell Pharmacol. 2009. PMID: 20419052 Free PMC article.
-
Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma.J Anaesthesiol Clin Pharmacol. 2016 Jul-Sep;32(3):387-8. doi: 10.4103/0970-9185.173346. J Anaesthesiol Clin Pharmacol. 2016. PMID: 27625493 Free PMC article.
-
Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.Br J Clin Pharmacol. 2007 Aug;64(2):210-8. doi: 10.1111/j.1365-2125.2007.02847.x. Epub 2007 Feb 12. Br J Clin Pharmacol. 2007. PMID: 17298482 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources